- Men and women
- Age: 18–70 years
- Diagnosis of Narcolepsy Type 1 and/or Type 2*
- Diagnosis of Idiopathic Hypersomnia*
*Diagnosis can also be established at our centre.
Sleep: Excessive daytime sleepiness
Research into possible treatments for individuals living with narcolepsy or hypersomnia
Safe and reliable participation
✓ Always under medical supervision
✓ Maximum focus on your data privacy (GDPR)
✓ Over +7,500 participants have gone before you
About this study project
Narcolepsy and hypersomnia are chronic neurological sleep-wake disorders characterised by dysregulation of the sleep-wake cycle, which can significantly impair daily functioning and quality of life. This study investigates a potential pharmacological treatment for adults diagnosed with narcolepsy or hypersomnia.
These conditions are associated with the following clinical manifestations:
- Persistent excessive daytime sleepiness and severe fatigue
- Sudden involuntary sleep episodes during waking hours
- Cognitive impairment, including difficulties with concentration and memory
- Disrupted nocturnal sleep architecture and impaired daytime vigilance
Study objective:
This ANIMA Research study evaluates an investigational medicinal product in patients diagnosed with narcolepsy (type 1 and/or 2) or idiopathic hypersomnia, compared to a placebo control group. The therapeutic approach targets the underlying pathophysiological mechanism of the disorder, rather than solely addressing symptomatic management.
Criteria
How to participate
- Register via the online form; you will receive a confirmation e-mail
- Our team will contact you for further follow-up and to assess whether participation is clinically appropriate
- Begin participation under medical supervision, including a treatment period and follow-up visits
You will receive personalised guidance from our team of physicians and researchers throughout the study. You are encouraged to ask questions at any stage and will receive support at every step to ensure you feel informed and clinically well-supported.
Why your participation matters
By participating, you contribute to the clinical understanding of how individuals with excessive daytime sleepiness respond to a potential therapeutic intervention. The data collected will support the further development of this treatment and may generate valuable evidence for future clinical care.
